Insights

Global Expansion CARsgen Therapeutics has expanded its facilities in the U.S., indicating growth and potential sales opportunities in the American market.

Innovative Platforms The development of the THANK-u Plus platform showcases CARsgen's commitment to innovation, presenting a unique selling point for targeted therapy solutions.

Research Presentations CARsgen's active participation and presentation of research results at major industry events like EHA and ASCO indicate a strong presence in the scientific community, offering avenues for collaborations and product sales.

Investment in Technology Utilization of technologies such as SAS, jQuery, and Google Analytics demonstrates a tech-savvy approach that could appeal to companies seeking advanced biotech solutions.

Competitive Positioning Being in the same revenue range as established companies like GRAIL, Legend Biotech, and Zai Lab positions CARsgen as a strong competitor, indicating potential opportunities to capture market share.

CARsgen Therapeutics Tech Stack

CARsgen Therapeutics uses 8 technology products and services including Quickbooks Online, SAS, jQuery, and more. Explore CARsgen Therapeutics's tech stack below.

  • Quickbooks Online
    Accounting
  • SAS
    Business Intelligence
  • jQuery
    Javascript Libraries
  • HSTS
    Security
  • X-XSS-Protection
    Security
  • Animate.css
    UI Frameworks
  • Bootstrap
    UI Frameworks
  • Google Analytics
    Web Analytics

Media & News

CARsgen Therapeutics's Email Address Formats

CARsgen Therapeutics uses at least 1 format(s):
CARsgen Therapeutics Email FormatsExamplePercentage
FirstLast@carsgen.comJohnDoe@carsgen.com
55%
First.Last@carsgen.comJohn.Doe@carsgen.com
29%
FirstLa@carsgen.comJohnDo@carsgen.com
11%
FirLast@carsgen.comJohDoe@carsgen.com
5%

Frequently Asked Questions

Where is CARsgen Therapeutics's headquarters located?

Minus sign iconPlus sign icon
CARsgen Therapeutics's main headquarters is located at Suite401, Building 3, No.466, Yindu Rd Shanghai, 200231 CN. The company has employees across 3 continents, including North AmericaAsiaEurope.

What is CARsgen Therapeutics's phone number?

Minus sign iconPlus sign icon
You can contact CARsgen Therapeutics's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is CARsgen Therapeutics's official website and social media links?

Minus sign iconPlus sign icon
CARsgen Therapeutics's official website is carsgen.com and has social profiles on LinkedIn.

How much revenue does CARsgen Therapeutics generate?

Minus sign iconPlus sign icon
As of July 2025, CARsgen Therapeutics's annual revenue reached $750M.

What is CARsgen Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign icon
CARsgen Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does CARsgen Therapeutics have currently?

Minus sign iconPlus sign icon
As of July 2025, CARsgen Therapeutics has approximately 100 employees across 3 continents, including North AmericaAsiaEurope. Key team members include Chief Medical Officer: R. B.Chief Operations Officer: H. W.Head Of Technical Operations: B. B. H.. Explore CARsgen Therapeutics's employee directory with LeadIQ.

What industry does CARsgen Therapeutics belong to?

Minus sign iconPlus sign icon
CARsgen Therapeutics operates in the Biotechnology Research industry.

What technology does CARsgen Therapeutics use?

Minus sign iconPlus sign icon
CARsgen Therapeutics's tech stack includes Quickbooks OnlineSASjQueryHSTSX-XSS-ProtectionAnimate.cssBootstrapGoogle Analytics.

What is CARsgen Therapeutics's email format?

Minus sign iconPlus sign icon
CARsgen Therapeutics's email format typically follows the pattern of . Find more CARsgen Therapeutics email formats with LeadIQ.

How much funding has CARsgen Therapeutics raised to date?

Minus sign iconPlus sign icon
As of July 2025, CARsgen Therapeutics has raised $246M in funding. The last funding round occurred on Mar 01, 2020 for $60M.

When was CARsgen Therapeutics founded?

Minus sign iconPlus sign icon
CARsgen Therapeutics was founded in 2014.
CARsgen Therapeutics

CARsgen Therapeutics

Biotechnology ResearchShanghai, China51-200 Employees

CARsgen is a biopharmaceutical company with operations in China and the U.S. focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors. The company has built an integrated cell therapy platform with in-house capabilities that span target discovery, antibody development, clinical trials, and commercial-scale manufacturing. CARsgen has internally developed novel technologies and a product pipeline with global rights to address major challenges of CAR T-cell therapies, such as improving the safety profile, enhancing the efficacy in treating solid tumors, and reducing treatment costs. Our vision is to become a global biopharmaceutical leader that brings innovative and differentiated cell therapies to cancer patients worldwide and makes cancer curable.

Media contact: pr@carsgen.com

Section iconCompany Overview

Headquarters
Suite401, Building 3, No.466, Yindu Rd Shanghai, 200231 CN
Phone number
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2014
Employees
51-200

Section iconFunding & Financials

  • $246M

    CARsgen Therapeutics has raised a total of $246M of funding over 2 rounds. Their latest funding round was raised on Mar 01, 2020 in the amount of $60Mas a Pre-C financing.

  • $100M$1B

    CARsgen Therapeutics's revenue is in the range of $100M$1B

Section iconFunding & Financials

  • $246M

    CARsgen Therapeutics has raised a total of $246M of funding over 2 rounds. Their latest funding round was raised on Mar 01, 2020 in the amount of $60Mas a Pre-C financing.

  • $100M$1B

    CARsgen Therapeutics's revenue is in the range of $100M$1B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.